Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoff McColl

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bulletin of the World Health Organization|January 6, 2015
Expensive medicines: ensuring objective appraisal and equitable accessSuzanne R Hill, Lisa Bero, Geoff McColl, et al.
BMC Medical Education|October 30, 2013
Analysing clinical reasoning characteristics using a combined methods approachMichele Groves, Marie-Louise Dick, Geoff McColl, et al.
Journal of Advanced Nursing|November 15, 2013
What counts as effective communication in nursing? Evidence from nurse educators' and clinicians' feedback on nurse interactions with simulated patientsSally O'Hagan, Elizabeth Manias, Catherine Elder, et al.
Arthritis and Rheumatism|January 16, 2003
Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammationMelinda Wong, Ling Toh, Andrew Wilson, et al.
Arthritis and Rheumatism|October 2, 2002
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisJohn Moore, Peter Brooks, Sam Milliken, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2018
An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label TrialAn Tran-Duy, Marjan Ghiti Moghadam, Martijn A H Oude Voshaar, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bulletin of the World Health Organization|January 6, 2015
Expensive medicines: ensuring objective appraisal and equitable accessSuzanne R Hill, Lisa Bero, Geoff McColl, et al.
BMC Medical Education|October 30, 2013
Analysing clinical reasoning characteristics using a combined methods approachMichele Groves, Marie-Louise Dick, Geoff McColl, et al.
Journal of Advanced Nursing|November 15, 2013
What counts as effective communication in nursing? Evidence from nurse educators' and clinicians' feedback on nurse interactions with simulated patientsSally O'Hagan, Elizabeth Manias, Catherine Elder, et al.
Arthritis and Rheumatism|January 16, 2003
Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammationMelinda Wong, Ling Toh, Andrew Wilson, et al.
Arthritis and Rheumatism|October 2, 2002
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisJohn Moore, Peter Brooks, Sam Milliken, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2018
An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label TrialAn Tran-Duy, Marjan Ghiti Moghadam, Martijn A H Oude Voshaar, et al.
Pageof 2